1. Exploring amyloid oligomers with peptide model systems
- Author
-
Samdin, Tuan D, Kreutzer, Adam G, and Nowick, James S
- Subjects
Acquired Cognitive Impairment ,Aging ,Neurodegenerative ,Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD) ,Brain Disorders ,Neurosciences ,Alzheimer's Disease ,Rare Diseases ,Dementia ,2.1 Biological and endogenous factors ,Aetiology ,Neurological ,Amyloid ,Amyloid beta-Peptides ,Crystallography ,X-Ray ,Diabetes Mellitus ,Type 2 ,Humans ,Models ,Molecular ,Peptide Fragments ,Amyloidogenic peptides and proteins ,a-Synuclein ,Superoxide dismutase 1 ,aB crystallin ,Human ,prion protein hPrP ,Amyloid oligomers ,Fibrils ,Model peptide systems ,Stabilized 0-hairpins ,Macrocyclic ,0-hairpin peptides ,X-ray crystallography ,NMR ,CryoEM ,Molecular ,modeling ,Human prion protein hPrP ,Macrocyclic β-hairpin peptides ,Molecular docking ,Molecular modeling ,Oligomer mimics ,Peptide fragments ,Stabilized β-hairpins ,α-Synuclein ,αB crystallin ,β-amyloid peptide ,Medicinal and Biomolecular Chemistry ,Biochemistry and Cell Biology ,Organic Chemistry - Abstract
The assembly of amyloidogenic peptides and proteins, such as the β-amyloid peptide, α-synuclein, huntingtin, tau, and islet amyloid polypeptide, into amyloid fibrils and oligomers is directly linked to amyloid diseases, such as Alzheimer's, Parkinson's, and Huntington's diseases, frontotemporal dementias, and type II diabetes. Although amyloid oligomers have emerged as especially important in amyloid diseases, high-resolution structures of the oligomers formed by full-length amyloidogenic peptides and proteins have remained elusive. Investigations of oligomers assembled from fragments or stabilized β-hairpin segments of amyloidogenic peptides and proteins have allowed investigators to illuminate some of the structural, biophysical, and biological properties of amyloid oligomers. Here, we summarize recent advances in the application of these peptide model systems to investigate and understand the structures, biological properties, and biophysical properties of amyloid oligomers.
- Published
- 2021